FIRST AMENDMENT TO CREDIT AGREEMENTCredit Agreement • February 11th, 2021 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • New York
This FIRST AMENDMENT TO CREDIT AGREEMENT, dated as of December 29, 2020 (this “Amendment”), by and among Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (the “Company”), the other Loan Parties (as defined in the Existing Credit Agreement (as defined below)) party hereto, the Lenders (as defined in the Existing Credit Agreement) party hereto (collectively, the “Consenting Lenders”), and Bank of America, N.A., (“Bank of America”) as administrative agent (in such capacity, the “Administrative Agent”). Capitalized terms used but not otherwise defined in this Amendment have the same meanings as specified in the Existing Credit Agreement (as defined below).
ContractJoint Development and Commercialization Agreement • February 11th, 2021 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • Massachusetts
[***] = Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i) not material and (ii) would cause competitive harm if publicly disclosed.
